In the financial year 2016/17, the Ypsomed Group generated consolidated sales totaling CHF 389.6 million (previous year: CHF 336.9 million). Compared with the previous year, this represents an increase in sales of 15.6 %. The operating results (EBIT) also increased by 24.4 % compared to the previous year, from CHF 44.4 million to CHF 55.3 million. Profitability at the EBIT level has therefore risen to 14.2 % (previous year: 13.2 %). This is largely due to the growth in sales in the two segments Delivery Systems and Diabetes Care, but also to improved cost-efficiency in production and sales. Compared with the previous year, the net profits rose by 29.1 % from CHF 35.8 million to CHF 46.2 million.
Download annual and semiannual reports
On this page you can download all financial publications of Ypsomed Holding AG covering the last ten years of business activity. If you prefer a printed copy, please use the order form on this page.